![1]()
News
Cost of preventable adult hospital stays topped $33 billion in 2017
June 23, 2020
Heart failure, diabetes, and COPD were the most expensive preventable conditions.
News
CVD risk continues to fall down to systolic BP of 90 mm HG
June 19, 2020
“From an individual level we can now say that in healthy individuals, a systolic pressure in the 90s is not too low. It is a positive thing.”
![1]()
Opinion
Preventing arrhythmias and QTc prolongation in COVID-19 patients on psychotropics
June 18, 2020
Psychotropics associated with QTc interval prolongation should be discontinued (or substituted with a low-risk agent) if a patient presents with suspected COVID-19.
![1]()
News
DAPA-HF: Dapagliflozin slows T2D onset in heart failure patients
June 16, 2020
In the landmark DAPA-HF trial that enrolled HFrEF patients without diabetes, treatment with dapagliflozin cut incident type 2 diabetes by a relative 32%.
News
Mortality differs by LVEF between women and men
June 12, 2020
An Australian big-data study shows that a left-ventricular ejection fraction above 70% in women spells trouble
![1]()
News
Aspirin and warfarin together leads to increased bleeding without reducing thrombotic events
June 9, 2020
In patients taking warfarin for atrial fibrillation (AFib) or venous thromboembolism (VTE), how often is aspirin used without a clear indication, and what are the clinical outcomes for these patients?
![1]()
News
Catheter ablation of AFib improves quality of life more than medications do
June 8, 2020
Does catheter ablation of atrial fibrillation (AFib) improve quality of life (QOL) compared to medication therapy?
![1]()
News
QI initiative can decrease unnecessary IV treatment of asymptomatic hypertension
June 5, 2020
How common is treatment of asymptomatic hypertension in the hospital with IV medications and what is the impact of a quality improvement initiative to reduce use?
News
Lancet, NEJM retract studies on hydroxychloroquine for COVID-19
June 4, 2020
The Lancet issued a retraction of an influential study of hydroxychloroquine use in COVID-19 patients. Hours later, NEJM retracted a second study from the same group.
![1]()
News
More fatalities in heart transplant patients with COVID-19
June 4, 2020
A new study suggests a high risk for death if heart transplant patients contract COVID-19, which points to the need for increased precautions and vigilance.
